9007

    500672

    NOVARTIND

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Novartis India Limited Share Price Today

    NOVARTIS INDIA LIMITED is currently trading at ₹1537.1, down by ₹38.4 from the previous close. The stock touched an intraday high of ₹1607.40 and a low of ₹1519.00 during the latest trading session. Over the past one year, NOVARTIS INDIA LIMITED has delivered a return of 0.0%, while the stock has gained 7.15% in the last one month.

    Novartis India Limited performance

    Today’s low Today’s high
    ₹ 1519.00 ₹ 1607.40
    ₹ 1537.10
    52 week low 52 week high
    ₹ 950.00 ₹ 1780.00
    ₹ 1537.10
    Open Price ₹ 1575.50
    Prev. Close ₹ 1575.50
    Volume (Shares) 27976.00
    Total traded value ₹ 430.01
    Upper Circuit ₹ 1890.60
    Lower Circuit ₹ 1260.40
    info

    Investment Returns

    Over 1 Month 7.15% Over 3 Months 49.16% Over 6 Months 54.41% Over 1 Year 0.00%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Novartis India Limited fundamentals


    • Market cap (Cr) 3,795.20
    • P/E Ratio (TTM) 39.00
    • Beta -0.61
    • Book Value / share 331.23
    • Return on equity 13.19%
    • EPS (TTM) 39.60
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 32.21
    info icon alternate text
    • Market cap (Cr) 3,813.00
    • P/E Ratio (TTM) 39.00
    • Beta 0.18
    • Book Value / share 331.23
    • Return on equity 13.19%
    • EPS (TTM) 39.60
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 32.21
    info icon alternate text

    Novartis India Limited Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 103.81
    Operating Expense 69.38
    Net Profit 32.21
    Net Profit Margin (%) 31.02
    Earnings Per Share (EPS) 13.05
    EBITDA 43.65
    Effective Tax Rate (%) 25.38
    Particulars MAR 2026 (Values in Cr)
    Revenue 90.55
    Operating Expense 70.41
    Net Profit 25.25
    Net Profit Margin (%) 27.88
    Earnings Per Share (EPS) 10.23
    EBITDA 30.63
    Effective Tax Rate (%) 16.22
    Particulars DEC 2025 (Values in Cr)
    Revenue 85.90
    Operating Expense 65.00
    Net Profit 16.09
    Net Profit Margin (%) 18.73
    Earnings Per Share (EPS) 6.52
    EBITDA 31.11
    Effective Tax Rate (%) 45.73
    Particulars SEP 2025 (Values in Cr)
    Revenue 90.33
    Operating Expense 67.08
    Net Profit 24.22
    Net Profit Margin (%) 26.81
    Earnings Per Share (EPS) 9.81
    EBITDA 33.28
    Effective Tax Rate (%) 25.81
    Particulars JUN 2025 (Values in Cr)
    Revenue 87.55
    Operating Expense 60.94
    Net Profit 27.62
    Net Profit Margin (%) 31.54
    Earnings Per Share (EPS) 11.19
    EBITDA 37.85
    Effective Tax Rate (%) 25.79
    Particulars MAR 2026 (Values in Cr)
    Revenue 354.33
    Operating Expense 263.44
    Net Profit 93.18
    Net Profit Margin (%) 26.29
    Earnings Per Share (EPS) 37.74
    EBITDA 132.86
    Effective Tax Rate (%) 28.13
    Particulars MAR 2025 (Values in Cr)
    Revenue 356.27
    Operating Expense 267.81
    Net Profit 100.90
    Net Profit Margin (%) 28.32
    Earnings Per Share (EPS) 40.87
    EBITDA 133.38
    Effective Tax Rate (%) 22.63
    Particulars MAR 2024 (Values in Cr)
    Revenue 335.07
    Operating Expense 273.91
    Net Profit 85.19
    Net Profit Margin (%) 25.42
    Earnings Per Share (EPS) 34.50
    EBITDA 126.94
    Effective Tax Rate (%) 30.64
    Particulars MAR 2023 (Values in Cr)
    Revenue 378.74
    Operating Expense 321.47
    Net Profit 103.36
    Net Profit Margin (%) 27.29
    Earnings Per Share (EPS) 41.86
    EBITDA 123.19
    Effective Tax Rate (%) 10.41
    Particulars MAR 2022 (Values in Cr)
    Revenue 399.87
    Operating Expense 387.24
    Net Profit -3.72
    Net Profit Margin (%) -0.93
    Earnings Per Share (EPS) -1.51
    EBITDA 10.66
    Effective Tax Rate (%) 2.61
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 318.06
    ROE % 13.19
    ROCE % 16.64
    Total Debt to Total Equity 0.01
    EBITDA Margin 34.19
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 301.79
    ROE % 11.21
    ROCE % 15.57
    Total Debt to Total Equity 0.02
    EBITDA Margin 34.60
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 314.29
    ROE % 14.09
    ROCE % 14.88
    Total Debt to Total Equity 0.03
    EBITDA Margin 29.79
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 280.27
    ROE % 5.84
    ROCE % 5.66
    Total Debt to Total Equity 0.06
    EBITDA Margin 11.30
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 288.16
    ROE % 2.92
    ROCE % 5.57
    Total Debt to Total Equity 0.09
    EBITDA Margin 13.20
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 648.03
    Total Assets 947.81
    Total Liabilities 947.81
    Total Equity 784.96
    Share Outstanding 2
    Price to Book Ratio 2.47
    Return on Assets (%) 10.64
    Return on Capital (%) 12.85
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 596.08
    Total Assets 924.93
    Total Liabilities 924.93
    Total Equity 744.82
    Share Outstanding 2
    Price to Book Ratio 3.41
    Return on Assets (%) 9.21
    Return on Capital (%) 11.44
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 555.94
    Total Assets 982.94
    Total Liabilities 982.94
    Total Equity 775.66
    Share Outstanding 2
    Price to Book Ratio 1.80
    Return on Assets (%) 10.51
    Return on Capital (%) 13.33
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 517.63
    Total Assets 957.57
    Total Liabilities 957.57
    Total Equity 691.70
    Share Outstanding 2
    Price to Book Ratio 2.11
    Return on Assets (%) -0.38
    Return on Capital (%) -0.54
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 498.88
    Total Assets 1002.29
    Total Liabilities 1002.29
    Total Equity 711.19
    Share Outstanding 2
    Price to Book Ratio 1.92
    Return on Assets (%) 2.08
    Return on Capital (%) 2.94
    Particulars MAR 2024 (Values in Cr)
    Net Income 122.84
    Cash from Operations 75.13
    Cash from Investing 33.13
    Cash from Financing -120.99
    Net change in Cash 25.54
    Free Cash Flow 75.13
    Particulars MAR 2023 (Values in Cr)
    Net Income 115.38
    Cash from Operations 42.46
    Cash from Investing -153.25
    Cash from Financing -30.48
    Net change in Cash -138.93
    Free Cash Flow 42.77
    Particulars MAR 2022 (Values in Cr)
    Net Income -3.82
    Cash from Operations 57.26
    Cash from Investing 87.04
    Cash from Financing -35.63
    Net change in Cash 90.08
    Free Cash Flow 57.76
    Particulars MAR 2021 (Values in Cr)
    Net Income 40.04
    Cash from Operations -34.02
    Cash from Investing 95.16
    Cash from Financing -36.80
    Net change in Cash -10.85
    Free Cash Flow -33.93
    Particulars MAR 2020 (Values in Cr)
    Net Income 28.64
    Cash from Operations 14.99
    Cash from Investing 55.91
    Cash from Financing -41.41
    Net change in Cash -8.64
    Free Cash Flow 15.99
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 34.87 14.47 1.68 267.22 23.12 38.85
    BLISS GVS PHARMA LTD 467.40 37.63 4.16 4965.84 118.35 552.90
    CIPLA LTD 1472.95 33.25 3.45 118991.58 1165.55 1672.20
    FERMENTA BIOTECH LTD. 501.25 23.44 3.62 1475.23 256.40 507.20
    GLAXOSMITHKLINE PHARMA LT 2653.45 46.72 19.82 44951.04 2088.00 3202.80
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 34.87 24.38 4.49 267.22 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 515.00 23.08 4.02 1488.90 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8103.65 105.90 23.21 20259.13 7630.00 9850.00
    BLISS GVS PHARMA LTD 467.40 50.58 4.29 4965.84 118.35 552.90

    Novartis India Limited shareholding pattern

    Holding
    27.8%
    70.67%
    0.16%
    1.35%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    Novartis India Limited Technicals Summary

    1537.10 -2.43 redarrow
    red-green-graph indicator
    12 Bearish
    4 Bullish
    • 5 Days 1580.60
    • 26 Days 1549.00
    • 10 Days 1593.90
    • 50 Days 1446.90
    • 12 Days 1592.30
    • 100 Days 1264.60
    • 20 Days 1570.90
    • 200 Days 1061.30
    1600.90 PIVOT
    First Support 1544.00 First Resistance 1632.40 Second Support 1512.50 Second Resistance 1689.30 Third Support 1455.60 Third Resistance 1720.80
    RSI 49.00 ADX 48.80 MACD 43.31 Williams % R -88.75 Commodity Channel Index (CCI) -31.42
    Date 2026-07-31 Week 17994.00 Same Day 16383.00 Month 18160.00
    1 Year -0.61 3 Year -0.21
    Over 1 Month
    7.15% down
    Over 1 Year
    0.00% down
    Over 3 Months
    49.16% down
    Over 3 Years
    28.56% down
    Over 6 Months
    54.41% down
    Over 5 Years
    9.57% down

    Novartis India Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    23 Jul 2025 25.0 Final 23 Jul 2025 Equity shares
    23 Jul 2024 25.0 Final 24 Jul 2024 Equity shares
    20 Jul 2023 37.5 Special 21 Jul 2023 Equity shares
    20 Jul 2023 10.0 Final 21 Jul 2023 Equity shares
    20 Jul 2022 10.0 Final 22 Jul 2022 Equity shares
    17 Aug 2021 10.0 Final 20 Aug 2021 Equity shares
    29 Jul 2020 10.0 Final 31 Jul 2020 Equity shares
    31 Jul 2019 10.0 Final 02 Aug 2019 Equity shares
    18 Jul 2018 10.0 Final 20 Jul 2018 Equity shares
    19 Jul 2017 10.0 Final 21 Jul 2017 Equity shares
    21 Jul 2016 10.0 Final 22 Jul 2016 Equity shares
    14 Jul 2015 10.0 Final 16 Jul 2015 Equity shares
    16 Jul 2014 5.0 Final 18 Jul 2014 Equity shares
    16 Jul 2013 10.0 Final 18 Jul 2013 Equity shares
    18 Jul 2012 10.0 Final 20 Jul 2012 Equity shares
    18 Jul 2011 10.0 Final 20 Jul 2011 Equity shares
    21 Jul 2010 10.0 Final 23 Jul 2010 Equity shares
    08 Jul 2009 10.0 Final 10 Jul 2009 Equity shares
    07 Jul 2008 10.0 Final 09 Jul 2008 Equity shares
    22 Mar 2007 10.0 Final 23 Mar 2007 Equity shares
    20 Jul 2005 0.0 Final 22 Jul 2005 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    23 Jul 2025 25.0 Final 23 Jul 2025 Equity shares
    23 Jul 2024 25.0 Final 24 Jul 2024 Equity shares
    20 Jul 2023 37.5 Special 21 Jul 2023 Equity shares
    20 Jul 2023 10.0 Final 21 Jul 2023 Equity shares
    20 Jul 2022 10.0 Final 22 Jul 2022 Equity shares
    17 Aug 2021 10.0 Final 20 Aug 2021 Equity shares
    29 Jul 2020 10.0 Final 31 Jul 2020 Equity shares
    31 Jul 2019 10.0 Final 02 Aug 2019 Equity shares
    18 Jul 2018 10.0 Final 20 Jul 2018 Equity shares
    19 Jul 2017 10.0 Final 21 Jul 2017 Equity shares
    21 Jul 2016 10.0 Final 22 Jul 2016 Equity shares
    14 Jul 2015 10.0 Final 16 Jul 2015 Equity shares
    16 Jul 2014 5.0 Final 18 Jul 2014 Equity shares
    16 Jul 2013 10.0 Final 18 Jul 2013 Equity shares
    18 Jul 2012 10.0 Final 20 Jul 2012 Equity shares
    18 Jul 2011 10.0 Final 20 Jul 2011 Equity shares
    21 Jul 2010 10.0 Final 23 Jul 2010 Equity shares
    08 Jul 2009 10.0 Final 10 Jul 2009 Equity shares
    07 Jul 2008 10.0 Final 09 Jul 2008 Equity shares
    22 Mar 2007 10.0 Final 23 Mar 2007 Equity shares
    20 Jul 2005 0.0 Final 22 Jul 2005 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Novartis India Ltd?

    Answer Field

    Novartis India Ltd share price is for NSE ₹ 1,537.10 & for BSE ₹ 1,565.90 as on Jul 31 2026 03:30 PM.

    What is the Market Cap of Novartis India Ltd Share?

    Answer Field

    The market cap of Novartis India Ltd for NSE ₹ 3,795.20 & for BSE ₹ 0.00 as on Jul 31 2026 03:30 PM.

    What is the 52 Week High and Low of Novartis India Ltd?

    Answer Field

    The 52 Week High and Low of Novartis India Ltd for NSE is ₹ 1,780.00 and ₹ 950.00 and for BSE is ₹ 1,777.50 and ₹ 750.00.

    What is 1 year return for Novartis India Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.00%.

    What is the P/E Ratio of Novartis India Ltd Share?

    Answer Field

    As on Jul 31 2026 03:30 PM the price-to-earnings (PE) ratio for Novartis India Ltd share is 39.00.

    What is the PB ratio of Novartis India Ltd Share?

    Answer Field

    As on Jul 31 2026 03:30 PM, the price-to-book (PB) ratio for Novartis India Ltd share is 331.23.

    How to Buy Novartis India Ltd Share?

    Answer Field

    You can trade in Novartis India Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Novartis India Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Novartis India Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Novartis India Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |